Cost-Effective Care Coordination for People With Dementia at Home.
Care management
Cognitive impairment
Community health worker
Medicaid
Medicare
Journal
Innovation in aging
ISSN: 2399-5300
Titre abrégé: Innov Aging
Pays: England
ID NLM: 101703706
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
07
2019
entrez:
9
1
2020
pubmed:
9
1
2020
medline:
9
1
2020
Statut:
epublish
Résumé
People with dementia (PWD) represent some of the highest-need and highest-cost individuals living in the community. Maximizing Independence (MIND) at Home is a potentially cost-effective and scalable home-based dementia care coordination program that uses trained, nonclinical community workers as the primary contact between the PWD and their care partner, supported by a multidisciplinary clinical team with expertise in dementia care. Cost of care management services based on actual time spent by care management personnel over first 12 months of MIND at Home intervention was calculated for 342 MIND at Home recipients from Baltimore, Maryland and surrounding areas participating in a Centers for Medicare and Medicaid Services (CMS) funded Health Care Innovation Award demonstration project. Difference-in-differences analysis of claims-based Medicaid spending of 120 dually-eligible MIND at Home participants with their propensity score matched comparison group ( The average cost per enrollee per month was $110, or $1,320 per annum. Medicaid expenditures of dually-eligible participants grew 1.12 percentage points per quarter more slowly than that of the matched comparison group. Most savings came from slower growth in inpatient and long-term nursing home use. Net of the cost of the 5-year MIND at Home intervention, 5-year Medicaid savings are estimated at $7,052 per beneficiary, a 1.12-fold return on investment. Managed care plans with the flexibility to engage community health workers could benefit from a low-cost, high-touch intervention to meet the needs of enrollees with dementia. Limitations for using and reimbursing community health workers exist in Medicare fee-for-service, which CMS should address to maximize benefit for PWD.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
People with dementia (PWD) represent some of the highest-need and highest-cost individuals living in the community. Maximizing Independence (MIND) at Home is a potentially cost-effective and scalable home-based dementia care coordination program that uses trained, nonclinical community workers as the primary contact between the PWD and their care partner, supported by a multidisciplinary clinical team with expertise in dementia care.
RESEARCH DESIGN AND METHODS
METHODS
Cost of care management services based on actual time spent by care management personnel over first 12 months of MIND at Home intervention was calculated for 342 MIND at Home recipients from Baltimore, Maryland and surrounding areas participating in a Centers for Medicare and Medicaid Services (CMS) funded Health Care Innovation Award demonstration project. Difference-in-differences analysis of claims-based Medicaid spending of 120 dually-eligible MIND at Home participants with their propensity score matched comparison group (
RESULTS
RESULTS
The average cost per enrollee per month was $110, or $1,320 per annum. Medicaid expenditures of dually-eligible participants grew 1.12 percentage points per quarter more slowly than that of the matched comparison group. Most savings came from slower growth in inpatient and long-term nursing home use. Net of the cost of the 5-year MIND at Home intervention, 5-year Medicaid savings are estimated at $7,052 per beneficiary, a 1.12-fold return on investment.
DISCUSSION AND IMPLICATIONS
CONCLUSIONS
Managed care plans with the flexibility to engage community health workers could benefit from a low-cost, high-touch intervention to meet the needs of enrollees with dementia. Limitations for using and reimbursing community health workers exist in Medicare fee-for-service, which CMS should address to maximize benefit for PWD.
Identifiants
pubmed: 31911954
doi: 10.1093/geroni/igz051
pii: igz051
pmc: PMC6938464
doi:
Types de publication
Journal Article
Langues
eng
Pagination
igz051Subventions
Organisme : NIA NIH HHS
ID : P30 AG059298
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066507
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America.
Références
Cochrane Database Syst Rev. 2015 Jan 05;1:CD008345
pubmed: 25560977
JAMA Intern Med. 2018 Dec 1;178(12):1635-1643
pubmed: 30422224
Issue Brief (Commonw Fund). 2017 Nov 01;2017:1-9
pubmed: 29232085
Contemp Clin Trials. 2018 Aug;71:103-112
pubmed: 29783091
N Engl J Med. 2016 Dec 8;375(23):2218-2220
pubmed: 27959672
Ann Intern Med. 2010 Oct 19;153(8):507-15
pubmed: 20956707
Alzheimers Dement. 2018 Jan;14(1):104-114
pubmed: 29161539
Health Aff (Millwood). 2014 Apr;33(4):626-32
pubmed: 24711324
Am J Manag Care. 2016 Nov;22(11):764-768
pubmed: 27870546
Am J Geriatr Psychiatry. 2015 Apr;23(4):391-402
pubmed: 25260557
Health Promot Pract. 2018 May;19(3):349-360
pubmed: 29363334
Am J Public Health. 2017 Oct;107(10):1660-1667
pubmed: 28817334
Health Aff (Millwood). 2014 Apr;33(4):619-25
pubmed: 24711323
Int J Care Coord. 2017 Dec;20(4):123-134
pubmed: 29607051
N Engl J Med. 2018 Jun 7;378(23):2153-2155
pubmed: 29874539
Health Serv Res. 2018 Feb;53(1):556-579
pubmed: 28083879
Health Aff (Millwood). 2015 Oct;34(10):1642-9
pubmed: 26438739
Am J Geriatr Psychiatry. 2014 Apr;22(4):398-414
pubmed: 24502822
N Engl J Med. 2013 Apr 4;368(14):1326-34
pubmed: 23550670
Am J Alzheimers Dis Other Demen. 2011 May;26(3):205-11
pubmed: 21378063
Am J Geriatr Psychiatry. 2011 Apr;19(4):382-91
pubmed: 20808120